MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Hu, S; Xu Monette, Zy; Tzankov, A; Green, T; Wu, L; Balasubramanyam, A; Liu, Wm; Visco, C; Li, Y; Miranda, Rn; Montes Moreno, S; Dybkaer, K; Chiu, A; Orazi, A; Zu, Y; Bhagat, G; Richards, Kl; Hsi, Ed; Choi, Ww; Zhao, X; van Krieken, Jh; Huang, Q; Huh, J; Ai, W; Ponzoni, Maurilio; Ferreri, Aj; Zhou, F; Slack, Gw; Gascoyne, Rd; Tu, M; Variakojis, D; Chen, W; Go, Rs; Piris, Ma; Møller, Mb; Medeiros, Lj; Young, Kh